Cellebrite DI (CLBT) reported Q1 non-GAAP earnings Wednesday of $0.10 per diluted share, up from $0.08 a year earlier.

Analysts polled by FactSet expected $0.08.

Revenue for the quarter ended March 31 was $107.5 million, compared with $89.6 million a year earlier.

Analysts surveyed by FactSet expected $109.3 million.

The company expects Q2 revenue of $110 million to $116 million. Analysts surveyed by FactSet expect $115.3 million.

Cellebrite said it now expects 2025 revenue of $470 million to $485 million, compared with a prior outlook of $480 million to $490 million. Analysts surveyed by FactSet expect $484.2 million.

The company's shares were down nearly 13% in recent premarket activity.